These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 8818650

  • 1. Replication-competent retrovirus produced by a 'split-function' third generation amphotropic packaging cell line.
    Chong H, Vile RG.
    Gene Ther; 1996 Jul; 3(7):624-9. PubMed ID: 8818650
    [Abstract] [Full Text] [Related]

  • 2. Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line.
    Garrett E, Miller AR, Goldman JM, Apperley JF, Melo JV.
    Virology; 2000 Jan 05; 266(1):170-9. PubMed ID: 10612671
    [Abstract] [Full Text] [Related]

  • 3. Safe and efficient ecotropic and amphotropic packaging lines for use in gene transfer experiments.
    Markowitz DG, Goff SP, Bank A.
    Trans Assoc Am Physicians; 1988 Jan 05; 101():212-8. PubMed ID: 3077729
    [Abstract] [Full Text] [Related]

  • 4. Construction and use of a safe and efficient amphotropic packaging cell line.
    Markowitz D, Goff S, Bank A.
    Virology; 1988 Dec 05; 167(2):400-6. PubMed ID: 2462307
    [Abstract] [Full Text] [Related]

  • 5. Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.
    Farson D, McGuinness R, Dull T, Limoli K, Lazar R, Jalali S, Reddy S, Pennathur-Das R, Broad D, Finer M.
    J Gene Med; 1999 Dec 05; 1(3):195-209. PubMed ID: 10738568
    [Abstract] [Full Text] [Related]

  • 6. [Efficient gene transfer mediated by retrovirus vector in leukemic cells].
    Fu J, Chen Z, Cen J.
    Zhonghua Zhong Liu Za Zhi; 1998 May 05; 20(3):178-80. PubMed ID: 10921000
    [Abstract] [Full Text] [Related]

  • 7. Retroviral gene transfer using safe and efficient packaging cell lines.
    Markowitz D, Hesdorffer C, Ward M, Goff S, Bank A.
    Ann N Y Acad Sci; 1990 May 05; 612():407-14. PubMed ID: 2291567
    [Abstract] [Full Text] [Related]

  • 8. Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.
    Sena-Esteves M, Hampl JA, Camp SM, Breakefield XO.
    J Gene Med; 2002 May 05; 4(3):229-39. PubMed ID: 12112640
    [Abstract] [Full Text] [Related]

  • 9. Construction of a safe and efficient retrovirus packaging cell line.
    Markowitz D, Goff S, Bank A.
    Adv Exp Med Biol; 1988 May 05; 241():35-40. PubMed ID: 3223411
    [Abstract] [Full Text] [Related]

  • 10. Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.
    Yu SS, Han E, Hong Y, Lee JT, Kim S, Kim S.
    Gene Ther; 2003 Apr 05; 10(8):706-11. PubMed ID: 12692599
    [Abstract] [Full Text] [Related]

  • 11. Recombinant retroviral vector interferes with the detection of amphotropic replication competent retrovirus in standard culture assays.
    Printz M, Reynolds J, Mento SJ, Jolly D, Kowal K, Sajjadi N.
    Gene Ther; 1995 Mar 05; 2(2):143-50. PubMed ID: 7719931
    [Abstract] [Full Text] [Related]

  • 12. Pathogenesis of replication competent retroviruses derived from mouse cells in immunosuppressed primates: implications for use of neoplastic cells as vaccine substrates.
    Purcell DF.
    Dev Biol (Basel); 2001 Mar 05; 106():187-98; discussion 199, 253-63. PubMed ID: 11761231
    [Abstract] [Full Text] [Related]

  • 13. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
    Qiao J, Moreno J, Sanchez-Perez L, Kottke T, Thompson J, Caruso M, Diaz RM, Vile R.
    Gene Ther; 2006 Oct 05; 13(20):1457-70. PubMed ID: 16724095
    [Abstract] [Full Text] [Related]

  • 14. Development of a novel trans-lentiviral vector that affords predictable safety.
    Wu X, Wakefield JK, Liu H, Xiao H, Kralovics R, Prchal JT, Kappes JC.
    Mol Ther; 2000 Jul 05; 2(1):47-55. PubMed ID: 10899827
    [Abstract] [Full Text] [Related]

  • 15. A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences.
    Chong H, Starkey W, Vile RG.
    J Virol; 1998 Apr 05; 72(4):2663-70. PubMed ID: 9525583
    [Abstract] [Full Text] [Related]

  • 16. Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research.
    Chen J, Reeves L, Sanburn N, Croop J, Williams DA, Cornetta K.
    Virology; 2001 Mar 30; 282(1):186-97. PubMed ID: 11259201
    [Abstract] [Full Text] [Related]

  • 17. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y, Sun S, Oparaocha I, Humeau L, Davis B, Cohen R, Binder G, Chang YN, Slepushkin V, Dropulic B.
    J Gene Med; 2005 Jun 30; 7(6):818-34. PubMed ID: 15693055
    [Abstract] [Full Text] [Related]

  • 18. Plat-E: an efficient and stable system for transient packaging of retroviruses.
    Morita S, Kojima T, Kitamura T.
    Gene Ther; 2000 Jun 30; 7(12):1063-6. PubMed ID: 10871756
    [Abstract] [Full Text] [Related]

  • 19. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
    Reuss S, Biese P, Cosset FL, Takeuchi Y, Uckert W.
    Gene Ther; 2007 Apr 30; 14(7):595-603. PubMed ID: 17235289
    [Abstract] [Full Text] [Related]

  • 20. A new retrovirus packaging cell for gene transfer constructed from amplified long terminal repeat-free chimeric proviral genes.
    Takahara Y, Hamada K, Housman DE.
    J Virol; 1992 Jun 30; 66(6):3725-32. PubMed ID: 1316479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.